MindMed to Participate in September Investor Conferences
Mind Medicine (MindMed) Inc. - Common Shares (MNMD)
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences:H.C. Wainwright 26th Annual Global Investment ConferenceFormat: PanelPanel Title: Psychedelics in Psychiatry: Breaking New Ground in Mood DisordersDate and Time: Tuesday, September 10, 2024 at 3:00 PM ETLocation: New York, NYBaird’s 2024 Global Healthcare ConferenceFormat: Fireside ChatDate and Time: Wednesday, September 11, 2024 at 12:15 PM ETLocation: New York, NYWebcast Link: Baird’s 2024 Global Healthcare Conference2024 Cantor Global Healthcare ConferenceFormat: Fireside ChatDate and Time: Tuesday, September, 17 at 10:20 AM ETLocation: New York, NYWebcast Link: 2024 Cantor Global Healthcare ConferenceAudio webcasts and replays of available presentations
Show less
Read more
Impact Snapshot
Event Time:
MNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNMD alerts
High impacting Mind Medicine (MindMed) Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MNMD
News
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $16.00 to $14.00. They now have a "buy" rating on the stock.MarketBeat
- MindMed Announces New Employee Inducement GrantsBusiness Wire
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its price target raised by analysts at HC Wainwright from $35.00 to $55.00. They now have a "buy" rating on the stock.MarketBeat
- Trials for psychedelic drug candidate for PTSD under scrutiny by FDA - report [Seeking Alpha]Seeking Alpha
- Lykos laying off 75% of workforce following FDA rejection of psychedelic drug for PTSD [Seeking Alpha]Seeking Alpha
MNMD
Earnings
- 8/13/24 - Beat
MNMD
Sec Filings
- 9/25/24 - Form 144
- 9/25/24 - Form 4
- 9/25/24 - Form 4
- MNMD's page on the SEC website